The device was discarded by the user facility and is not available for evaluation.The device history records were reviewed for this manufacturing lot and there were no discrepancies or unusual findings that relate to the reported event.Based on the information reviewed, there is no evidence to indicate the presence of a potential quality issue with respect to manufacturing, design, or labeling.The relationship between the event and the device is unknown and no surgical video is available for analysis.Capsular bag damage and vitreous loss are inherent risks of cataract surgery.Manufacturer's reference #: (b)(4).
|
A (b)(6) year-old female patient with a grade 3+ nuclear sclerotic cataract underwent cataract surgery on (b)(6) 2019 where the miloop device was used to section the cataractous lens into quadrants.After the first successful bisection, the surgeon removed the miloop from the eye, rotated the lens with a drysdale nucleus manipulator (storz), then reinserted the miloop and made the final lens cut.After removing the first 2 lens quadrants, the surgeon noticed a small posterior capsule tear at the 9:00 position (left eye, temporal incision) and vitreous loss.A vitrectomy was performed and a sulcus-fixated intraocular lens was implanted.Additional information has been requested.
|